Evidence map›Paper›PMID 42825803›Full record

ArticleHistochemistry and cell biology2026

Deletion of Cipc promotes regenerative myogenesis in mdx mice and is associated with increased myogenin expression.

Ting Xue, Yu Zhao, Jianhua Wang, Yanfei Xu, Zhun Gu, Jiqing Zheng

Abstract read
PubMed Publisher
In one paragraph

Article in Histochemistry and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ting Xue *Jiangsu Provincial Novel Anti-Tumor Targeted Drug Conjugate Engineering Research Center, Suzhou Chien-Shiung Institute of Technology, Suzhou, 215411, China. 0515@csit.edu.cn.
Yu Zhao *Jiangsu Provincial Novel Anti-Tumor Targeted Drug Conjugate Engineering Research Center, Suzhou Chien-Shiung Institute of Technology, Suzhou, 215411, China.
Jianhua Wang *Jiangsu Provincial Novel Anti-Tumor Targeted Drug Conjugate Engineering Research Center, Suzhou Chien-Shiung Institute of Technology, Suzhou, 215411, China.
Yanfei Xu *China Pharmaceutical University, Nanjing, 211198, China.
Zhun GuJiangsu Provincial Novel Anti-Tumor Targeted Drug Conjugate Engineering Research Center, Suzhou Chien-Shiung Institute of Technology, Suzhou, 215411, China.
Jiqing ZhengJiangsu Provincial Novel Anti-Tumor Targeted Drug Conjugate Engineering Research Center, Suzhou Chien-Shiung Institute of Technology, Suzhou, 215411, China.

Funding

Jiangsu Province High-Level Innovation and Entrepreneurship Talent Introduction Plan JSSCBS20221009Natural Science Foundation of the Jiangsu Higher Education Institutions 25KJB320013Qing Lan Project Su Teacher [2024]14Science Projects of Taicang City TC2022JC29Start-up Fund for New Ph.D. Researchers of Suzhou Chien-Shiung Institute of Technology 02220028Start-up Fund for New Ph.D. Researchers of Suzhou Chien-Shiung Institute of Technology 60000005Start-up Fund for New Ph.D. Researchers of Suzhou Chien-Shiung Institute of Technology 60000314Taicang Basic Research Project TC2022JC28Taicang Basic Research Project TC2023JC35
6 · The paper itself

Abstract

Skeletal muscle regeneration depends on satellite cells, which proliferate, differentiate, and fuse to repair damaged myofibers. Satellite-cell dysfunction contributes to defective regeneration in Duchenne muscular dystrophy (DMD), but the contribution of circadian regulators to this process remains incompletely understood. Here, we investigated the role of the CLOCK-interacting protein CIPC in satellite-cell differentiation and muscle regeneration in mdx mice. Satellite cell-specific deletion of Cipc increased centrally nucleated fibers and embryonic myosin heavy chain-positive regenerating fibers in dystrophic and ischemia-reperfusion-injured tibialis anterior muscles, and enhanced MyHC-positive myotube formation in primary cultures. Cipc deletion was accompanied by increased MyoD and myogenin mRNA expression and a higher number of myogenin-positive cells. RNA sequencing of day-3 differentiated satellite cells identified Mapk14/p38α and Elk1 as candidate upstream regulators associated with increased myogenin expression. Immunoblotting in three independent experiments further showed increased p38 and ELK-1 phosphorylation in Cipc-deficient satellite cells, without an apparent genotype-dependent change in total p38 or total ELK-1 abundance. These findings indicate that Cipc deletion enhances regenerative myogenesis in mdx mice and is associated with increased p38/ELK-1 signaling and myogenin expression. Because pathway inhibition, ELK-1 promoter-occupancy, and myogenin loss-of-function experiments were not performed, the p38/ELK-1-myogenin axis should be regarded as a candidate mechanism rather than an established causal pathway.

Indexed as

Gene DeletionMuscle DevelopmentMyogeninRegenerationAnimalsCells, CulturedMaleMiceMice, Inbred C57BLMice, Inbred mdxMuscle, SkeletalSatellite Cells, Skeletal MuscleMyogeninCipcDuchenne muscular dystrophyELK-1Myogeninp38 MAPKSatellite cell differentiation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.